Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy

Posted on by

JAMA Pediatrics
March 2022, Vol 176, No. 3, Pages 220-332
https://jamanetwork.com/journals/jamapediatrics/currentissue

 

Original Investigation
Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy
Nir Kugelman, MD; Chen Nahshon, MD; Pninit Shaked-Mishan, PhD; et al.
free access has active quiz
JAMA Pediatr. 2022;176(3):290-295. doi:10.1001/jamapediatrics.2021.5683
This cohort study evaluates maternal and neonatal COVID-19 antibody levels at delivery after receipt of a messenger RNA (mRNA) COVID-19 vaccine during the second trimester of pregnancy.